EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Peptonics: A new family of cell‐protecting surfactants for the recombinant expression of therapeutic proteins in mammalian cell cultures

Ka Zhang, Eduardo Barbieri, Jacob LeBarre, Shahid Rameez, Sigma Mostafa, Stefano Menegatti iD

Biotechnology Journal · 2024

DOI: 10.1002/biot.202300261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Ka Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA. Hauptthemen laut MEDLINE: Poloxamer, Surface-Active Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NC-VVIRAL, KBI Biopharma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polymer surfactants are key components of cell culture media as they prevent mechanical damage during fermentation in stirred bioreactors. Among cell‐protecting surfactants, Pluronics are widely utilized in biomanufacturing to ensure high cell viability and productivity. Monodispersity of monomer sequence and length is critical for the effectiveness of Pluronics—since minor deviations can damage the cells—but is challenging to achieve due to the stochastic nature of polymerization. Responding to this challenge, this study introduces Peptonics, a novel family of peptide and peptoid surfactants whose monomer composition and sequence are designed to achieve high cell viability and productivity at a fraction of chain length and cost of Pluronics. A designed ensemble of Peptonics was initially characterized via light scattering and tensiometry to select sequences whose phase behavior and tensioactivity align with those of Pluronics. Selected sequences were evaluated as cell‐protecting surfactants using Chinese hamster ovary (CHO) cells expressing therapeutic monoclonal antibodies (mAb). Peptonics IH‐T1010, ih‐T1010, and ih‐T1020 afforded high cell density (up to 3 × 10 7 cells mL −1 ) and viability (up to 95% within 10 days of culture), while reducing the accumulation of ammonia (a toxic metabolite) by ≈10% compared to Pluronic F‐68. Improved cell viability afforded high mAb titer (up to 5.5 mg mL −1 ) and extended the production window beyond 14 days; notably, Peptonic IH‐T1020 decreased mAb fragmentation and aggregation ≈5%, and lowered the titer of host cell proteins by 16% compared to Pluronic F‐68. These features can improve significantly the purification of mAbs, thus increasing their availability at a lower cost to patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PoloxamerSurface-Active AgentsCricetinaeAnimalsHumansCricetulusCHO CellsAntibodies, MonoclonalCell Culture TechniquesRecombinant Proteins

Stichwörter der Autor:innen

PeptonicsPluronicsantibodiesmammalian cellspeptoidssurfactants

Substanzen

PoloxamerSurface-Active AgentsAntibodies, MonoclonalRecombinant Proteins

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, North Carolina State University, Raleigh, North Carolina, USA.
  • KBI Biopharma, Durham, North Carolina, USA.
  • LigaTrap Technologies LLC, Raleigh, North Carolina, USA.
  • Merck & Co., Inc., Rahway, New Jersey, USA.
  • Biomanufacturing Training and Education Center (BTEC), North Carolina State University, Raleigh, North Carolina, USA.
  • North Carolina Viral Vector Initiative in Research and Learning (NC-VVIRAL), North Carolina State University, Raleigh, North Carolina, USA.

ORCID-Profile: Stefano Menegatti

Förderung

  • NC-VVIRAL
  • KBI Biopharma

Zitieren

APA

Zhang, K., Barbieri, E., LeBarre, J., Rameez, S., Mostafa, S., & Menegatti, S. (2024). Peptonics: A new family of cell‐protecting surfactants for the recombinant expression of therapeutic proteins in mammalian cell cultures. Biotechnology Journal. https://doi.org/10.1002/biot.202300261

Vancouver

Zhang K, Barbieri E, LeBarre J, Rameez S, Mostafa S, Menegatti S. Peptonics: A new family of cell‐protecting surfactants for the recombinant expression of therapeutic proteins in mammalian cell cultures. Biotechnology Journal. 2024. doi:10.1002/biot.202300261

BibTeX
@article{Zhang2024,
  author = {Zhang, Ka and Barbieri, Eduardo and LeBarre, Jacob and Rameez, Shahid and Mostafa, Sigma and Menegatti, Stefano},
  title = {Peptonics: A new family of cell‐protecting surfactants for the recombinant expression of therapeutic proteins in mammalian cell cultures},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202300261}
}
Kostenlos starten →